In conclusion, RAL ameliorated estrogen deficiency-induced obesity, adipogenesis, and adipose tissue hypertrophy as well as inflammation via distinct activation of canonical Wnt10b/β-catenin and non-canonical SFRP5 signaling. The gene discussed is SFRP5; the disease is obesity due to melanocortin 4 receptor deficiency.